Posted: February 2017 Peter Hammerman has been appointed Global Head, Oncology Translational Research at Novartis Institutes for BioMedical Research (NIBR). Previous to this appointment, Dr. Hammerman was a Medical Oncologist and […] Read more
Thomas Stinchcombe has been recruited to the Duke Cancer Institute (DCI) where he will be promoted to Professor of Medicine in Medical Oncology. Tom will help lead the thoracic oncology group […] Read more
Charles B. Simone II has been appointed the Medical Director of the Maryland Proton Treatment Center (MPTC). Previous to this appointment, Dr. Simone was Associate Professor of Radiation Oncology at […] Read more
Tony Mok has been selected by the American Society of Clinical Oncology (ASCO) as a candidate for the 2017 ASCO Board of Directors. Professor Mok is a professor in the Department […] Read more
Richard B. Gaynor will retire as Senior Vice President, Global Development and Medical Affairs, Lilly Oncology as of January 2017. Prior to joining Lilly, Dr. Gaynor was a professor of medicine […] Read more
Martin J. Edelman has been appointed Chairman of the Department of Hematology/Oncology and Deputy Director for Clinical Research at the Fox Chase Cancer Center in Philadelphia. He will also be the […] Read more
Dr. Philip Bonomi completed his service as Director of the Division of Hematology, Oncology and Cell Therapy at Rush University Medical Center, Chicago, US, a position he has held since […] Read more
David Ball was appointed Director of the Lung Tumour Stream for The Royal Melbourne Hospital, The Royal Women’s Hospital and the Peter MacCallum Cancer Centre, which are now part of […] Read more
The lung cancer research community lost a respected leader and significant contributor to the field with the passing of Robert B. Livingston, MD, a Professor of Medicine and Hematology-Oncology at […] Read more
Glen Weiss, MD, MBA, was named 2016 Healthcare Leadership Awards’ Researcher of the Year by AZ Business magazine. Dr. Weiss is Director of Clinical Research, Director of Phase I and II […] Read more